Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Total 13F shares
-
40,738,464
-
Share change
-
+7,117,517
-
Total reported value
-
$1,205,704,254
-
Put/Call ratio
-
68%
-
Price per share
-
$29.60
-
Number of holders
-
177
-
Value change
-
+$221,363,966
-
Number of buys
-
101
-
Number of sells
-
71
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2017
As of 31 Mar 2017,
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) was held by
177 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,738,464 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, CARLSON CAPITAL L P, PERCEPTIVE ADVISORS LLC, HealthCor Management, L.P., Tourbillon Capital Partners, L.P., Camber Capital Management LLC, FMR LLC, and ORBIMED ADVISORS LLC.
This page lists
177
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.